Last Updated : February 27, 2020
The CADTH Drug Portfolio Information Sessions are an opportunity to receive an update on our drug portfolio, including CADTH’s Common Drug Review (CDR), pan-Canadian Oncology Drug Review (pCODR), and Therapeutic Reviews. In addition, we will also provide updates on other CADTH programs such as patient engagement.
The sessions will be presented in English and can be attended in person or by webinar. Registration is now closed.
Patient Groups and Health Care Professionals
9:30 a.m. to 12:00 p.m. EDT
Pharmaceutical Industry and Consultants
1:30 p.m. to 4:00 p.m. EDT
Questions may be sent by email to [email protected]
Last Updated : February 27, 2020